Similar articles for PMID: 22311707

Year	Number of Results
1992	1
1996	1
1998	1
1999	2
2000	1
2001	1
2002	1
2003	2
2004	3
2005	2
2006	7
2007	4
2008	5
2009	1
2010	2
2011	2
2012	5
2013	6
2014	7
2015	9
2016	12
2017	6
2018	4
2020	2
2021	2
2022	5
2023	1
2024	0

1

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.

Fazio F, Lionetto L, Molinaro G, Bertrand HO, Acher F, Ngomba RT, Notartomaso S, Curini M, Rosati O, Scarselli P, Di Marco R, Battaglia G, Bruno V, Simmaco M, Pin JP, Nicoletti F, Goudet C. Fazio F, et al. Mol Pharmacol. 2012 May;81(5):643-56. doi: 10.1124/mol.111.074765. Epub 2012 Feb 6. Mol Pharmacol. 2012. PMID: 22311707

2

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, Vacca C, Gargaro M, Volpi C, Allegrucci M, Lionetto L, Simmaco M, Belladonna ML, Nicoletti F, Fallarino F. Fazio F, et al. Neuropharmacology. 2014 Jun;81:237-43. doi: 10.1016/j.neuropharm.2014.02.011. Epub 2014 Feb 21. Neuropharmacology. 2014. PMID: 24565643

3

Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.

Fazio F, Lionetto L, Curto M, Iacovelli L, Copeland CS, Neale SA, Bruno V, Battaglia G, Salt TE, Nicoletti F. Fazio F, et al. Neuropharmacology. 2017 Jan;112(Pt B):365-372. doi: 10.1016/j.neuropharm.2016.06.020. Epub 2016 Jun 21. Neuropharmacology. 2017. PMID: 27342123 Free article. Review.

4

The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.

Ulivieri M, Wierońska JM, Lionetto L, Martinello K, Cieslik P, Chocyk A, Curto M, Di Menna L, Iacovelli L, Traficante A, Liberatore F, Mascio G, Antenucci N, Giannino G, Vergassola M, Pittaluga A, Bruno V, Battaglia G, Fucile S, Simmaco M, Nicoletti F, Pilc A, Fazio F. Ulivieri M, et al. Schizophr Bull. 2020 Dec 1;46(6):1471-1481. doi: 10.1093/schbul/sbaa074. Schizophr Bull. 2020. PMID: 32506121 Free PMC article.

5

PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors.

Canudas AM, Di Giorgi-Gerevini V, Iacovelli L, Nano G, D'Onofrio M, Arcella A, Giangaspero F, Busceti C, Ricci-Vitiani L, Battaglia G, Nicoletti F, Melchiorri D. Canudas AM, et al. J Neurosci. 2004 Nov 17;24(46):10343-52. doi: 10.1523/JNEUROSCI.3229-04.2004. J Neurosci. 2004. PMID: 15548648 Free PMC article.

6

Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Battaglia G, Busceti CL, Molinaro G, Biagioni F, Traficante A, Nicoletti F, Bruno V. Battaglia G, et al. J Neurosci. 2006 Jul 5;26(27):7222-9. doi: 10.1523/JNEUROSCI.1595-06.2006. J Neurosci. 2006. PMID: 16822979 Free PMC article.

7

The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors.

Beqollari D, Kammermeier PJ. Beqollari D, et al. Eur J Pharmacol. 2008 Jul 28;589(1-3):49-52. doi: 10.1016/j.ejphar.2008.06.054. Epub 2008 Jun 19. Eur J Pharmacol. 2008. PMID: 18593581

8

Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.

Kłak K, Pałucha A, Brański P, Sowa M, Pilc A. Kłak K, et al. Amino Acids. 2007 Feb;32(2):169-72. doi: 10.1007/s00726-006-0316-z. Epub 2006 Aug 2. Amino Acids. 2007. PMID: 16868652

9

Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures.

Ngomba RT, Ferraguti F, Badura A, Citraro R, Santolini I, Battaglia G, Bruno V, De Sarro G, Simonyi A, van Luijtelaar G, Nicoletti F. Ngomba RT, et al. Neuropharmacology. 2008 Feb;54(2):344-54. doi: 10.1016/j.neuropharm.2007.10.004. Epub 2007 Oct 16. Neuropharmacology. 2008. PMID: 18022649

10

Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage.

Moyanova SG, Mastroiacovo F, Kortenska LV, Mitreva RG, Fardone E, Santolini I, Sobrado M, Battaglia G, Bruno V, Nicoletti F, Ngomba RT. Moyanova SG, et al. J Cereb Blood Flow Metab. 2011 Apr;31(4):1107-18. doi: 10.1038/jcbfm.2010.201. Epub 2010 Dec 15. J Cereb Blood Flow Metab. 2011. PMID: 21157475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year